Immutep LTD ADR buy Mori8
Start price
20.09.16
/
50%
€2.62
Target price
27.09.16
€3.60
Performance (%)
0.00%
End price
27.09.16
€2.62
Summary
This prediction ended on 27.09.16 with a price of €2.62. The BUY prediction by Mori8 closed unchanged from the start price. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immutep LTD ADR | -0.813% | -0.813% | -66.803% | -66.111% |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by Mori8 for this prediction
In the thread Immutep LTD ADR diskutieren
Das Unternehmen konzentriert sich auf die Immuntherapie von Krebs-Forschung.
Brokers have set a twelve-month consensus target price of $5.00 for the company, according to Zacks.